Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of fentanyl and dexmedetomidine dose combinations for recovery after infant cataract surgery
ChiCTR-IPR-15006112Phase 4Not yet recruiting
- Sponsor
- Eye, Ear, Nose, and Throat Hospital
- Start
- Mar 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl, dexmedetomidine and mivacurium in congenital cataract (5 arms), sponsored by Eye, Ear, Nose, and Throat Hospital. Primary endpoints: Time to recovery of spontaneous respiration, Time to extubation and 4 more. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
fentanyldexmedetomidinemivacurium
03
Conditions
congenital cataract
Beyond the preview
Go deeper on ChiCTR-IPR-15006112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006112.